Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07014865
Recruiting
Factors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Their Caregivers
Not applicable · Italy · 1 site
Registry update: 29 Aug 2025
NCT06906887
Recruiting
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
Phase 2 · United States · 1 site
Registry update: 28 Jul 2026
NCT07073989
Recruiting
Investigating the Impact of Afferent Stimulation on Proprioceptive Function in Post-Stroke Rehabilitation
Not applicable · Spain · 1 site
Registry update: 20 Jul 2025
NCT07180316
Recruiting
Comparison of the Occurrence of Postoperative Complications Between Robotic and Laparoscopic Surgery in Revision Bariatric Surgery
Not applicable · France · 2 sites
Registry update: 18 Sept 2025
NCT07344480
Recruiting
Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)
Not applicable · Germany · 1 site
Registry update: 18 Feb 2026
NCT06789601
Recruiting
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
Phase 1/2 · United States · 2 sites
Registry update: 19 Jun 2025
NCT06815029
Recruiting
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Phase 1 · United States · 1 site
Registry update: 22 Oct 2026
NCT06717958
Recruiting
Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation
Phase 2 · Germany · 19 sites
Registry update: 26 Aug 2026
NCT06934538
Recruiting
First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
Phase 1/2 · Belgium, France, United States · 9 sites
Registry update: 20 Oct 2026
NCT07824479
Recruiting
Predicting Efficacy of Preoperative Immunotherapy in Advanced Gastric Cancer
Not applicable · China · 1 site
Registry update: 17 Sept 2026
NCT07030881
Recruiting
Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy
Not applicable · China · 9 sites
Registry update: 26 Jun 2026
NCT06940180
Recruiting
Toripalimab With Chemotherapy for Sinus Cancer
Phase 2 · United States · 2 sites
Registry update: 31 Aug 2026
NCT07037901
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Phase 2 · Australia, Canada, Czechia, Germany, Spain, Hungary, New Zealand, Poland, United States · 85 sites
Registry update: 12 Aug 2026
NCT06959277
Recruiting
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
Not applicable · United States · 6 sites
Registry update: 5 Oct 2026
NCT06951893
Recruiting
Identification of Pre-surgical Phenotypic Indicators Predictive of Quality of Life Trajectories in Obese Patients Following Bariatric Surgery
Not applicable · France · 1 site
Registry update: 7 Oct 2026
2023-505834-84-00
Recruiting
A Phase 2 Study evaluating Epcoritamab in subjects with relapsed and refractory primary diffuse large B-cell lymphoma of the CNS treated with Lenalidomide and Rituximab
Phase 2/3 · France · 12 sites
Registry update: 22 Oct 2025
2024-512011-45-00
Recruiting
BreAK CRC (001) trial
Phase 1/2 · Belgium, France · 8 sites
Registry update: 3 Sept 2026
NCT06689488
Recruiting
Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates
Not applicable · Netherlands · 1 site
Registry update: 26 Jun 2026
NCT06948487
Recruiting
Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis
Not applicable · South Korea · 1 site
Registry update: 17 Jul 2025
NCT06939166
Recruiting
Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 15 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.